Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-01 Sale |
2022-11-03 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
196,308 | $2.768 | $543,381 | 22,780,065 (Direct) |
View |
2022-10-28 Sale |
2022-11-01 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
397,206 | $2.6654 | $1,058,697 | 22,976,373 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 6:50 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
393,616 | $2.8011 | $1,102,574 | 23,373,579 (Direct) |
View |
2022-10-24 Sale |
2022-10-26 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
393,946 | $2.5565 | $1,007,107 | 23,767,195 (Direct) |
View |
2022-10-20 Sale |
2022-10-24 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
398,092 | $2.4543 | $977,054 | 24,161,141 (Direct) |
View |
2022-10-18 Sale |
2022-10-20 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
409,880 | $2.5686 | $1,052,809 | 24,559,233 (Direct) |
View |
2022-10-14 Sale |
2022-10-18 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
411,265 | $2.6274 | $1,080,577 | 24,969,113 (Direct) |
View |
2022-10-12 Sale |
2022-10-14 5:30 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
418,337 | $2.7733 | $1,160,189 | 25,380,378 (Direct) |
View |
2022-10-10 Sale |
2022-10-12 7:58 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See Remarks |
414,010 | $2.8742 | $1,189,930 | 25,798,715 (Direct) |
View |
2022-10-03 Sale |
2022-10-04 9:55 pm |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
343,082 | $3.1216 | $1,070,965 | 133,652,732 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-30 Exercise |
2022-10-04 9:55 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
26,555,807 | $0 | 133,652,732 (Direct) |
View |
2021-11-17 Option Award |
2022-10-04 9:55 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See remarks |
25,782,354 | $0 | 133,652,732 (Direct) |
View |
2021-12-06 Conversion |
2021-12-08 8:07 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See Remarks |
150,000 | $0 | 82,431,106 (Direct) |
View |
2021-12-07 Gift |
2021-12-08 8:07 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R See Remarks |
150,000 | $0 | 82,431,106 (Direct) |
View |
2021-09-16 Option Award |
2021-09-20 9:43 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Kelly Jason R CEO & Founder |
82,581,106 | $0 | 82,581,106 (Direct) |
View |
Ownership |
2021-02-22 9:50 pm |
N/A N/A |
CM Life Sciences II Inc. | CMII | Kelly Jason R Director |
0 | $0 | 25,000 (Direct) |
View |